Alt E
I. Medizinische Klinik, Klinikum Rechts der Isar, Technische Universität München, Germany.
Am J Cardiol. 1999 Mar 11;83(5B):17D-23D. doi: 10.1016/s0002-9149(98)01038-8.
The development of implantable pacemakers in the clinical setting mirrors the implementation of advanced technical possibilities. In the United States, 83% of all pacemakers implanted in 1996 had rate response as a programmable option. A variety of sensors have been proposed and used for rate control. Among today's many concepts, accelerometer-controlled pacing is the most widely used rate-adaptive principle. Although the use of a second sensor is currently of proven benefit for only a limited number of patients, the concept of closed-loop pacing--implementing a negative feedback between pacing rate and the control signal--merits further investigation. This is of special importance in defibrillator patients whose myocardial contractility is generally limited. These patients are most sensitive to pacing rates that are too high for a given metabolic situation. The integration of rate-adaptive pacing into defibrillators is a natural consequence of the technical evolution.
临床环境中植入式起搏器的发展反映了先进技术可能性的应用。在美国,1996年植入的所有起搏器中有83%具备频率应答这一可编程选项。人们已经提出并使用了多种传感器来进行频率控制。在当今众多的概念中,加速度计控制的起搏是应用最广泛的频率自适应原理。尽管目前已证实仅对有限数量的患者使用第二个传感器有益,但闭环起搏的概念——在起搏频率和控制信号之间实现负反馈——值得进一步研究。这在心肌收缩力普遍受限的除颤器患者中尤为重要。这些患者对在给定代谢情况下过高的起搏频率最为敏感。将频率自适应起搏集成到除颤器中是技术发展的自然结果。